Stay Informed

Get email alerts when new recalls match your interests.

Recall data is updated hourly from official government sources. Very recent recalls may not yet appear. About our data sources

About

We make U.S. recall data searchable and accessible for consumers and businesses.

Site

FAQ
Browse by State
Statistics
Recall Classifications
About
Enterprise API

Legal

Privacy Policy
Terms of Service
Report Incorrect Info

Official Sources

FDA Recalls ↗
USDA FSIS ↗
CPSC Recalls ↗
NHTSA Recalls ↗

RSS Feed

Home
/
Brands
/
Compass Health Brands (Corporate Office)

Compass Health Brands (Corporate Office) Recalls

All product recalls associated with Compass Health Brands (Corporate Office).

Get alerts for this brand

Recall Summary

Total Recalls

1000

Past Year

1000

Class I (Serious)

Most Recent

Jan 2026

Data from FDA, USDA, CPSC, and NHTSA public records. Recall counts vary by company size, industry, and reporting practices. Always check official sources for current information.

Showing 4461–4480 of 21320 recalls

REX Pressure Therapy System (Compass Health) – User Manual Error (2023)

Error in the Introduction section of the user manual that indicates the device may be used for the prevention of deep vein thrombosis (DVT). Marketed without a 510k for this indication

Low

FDAMar 7, 2023Nationwide• Compass Health Brands (Corporate Office)

EarlyVue VS30 Vitals Monitor (Philips) – CO2 Measurement Risk (2023)

EarlyVue VS30 Vital Signs Monitor and EarlyVue VS30 Vitals monitor Missing Calibration Alarm, a risk of an inaccurate CO2 measurement which may lead to a failure to recognize a change in patient condition.

High

FDAMar 6, 2023Nationwide• Philips North America Llc

EarlyVue VS30 Vitals Monitor (Philips) – CO2 Measurement Risk (2023)

1...222 223224225 226...1066

Page 224 of 1066Next

High

FDAMar 6, 2023Nationwide• Philips North America Llc

ProxiDiagnost N90 R.1.0 (Philips) – Compliance Issue (2023)

Philips has identified a compliance issue where ProxiDiagnost N90 R.1.0, CombiDiagnost R90 R.1.0 and CombiDiagnost R90 R1.1 systems are missing a certification label required by the Food and Drug Administration (FDA).

Low

FDAMar 3, 2023Nationwide• Philips North America

CombiDiagnost R90 R.1.0 (Philips) – Compliance Issue (2023)

Low

FDAMar 3, 2023Nationwide• Philips North America

Central Hydraulics Motorcycle Lift (Central Hydraulics) – Weld Failure (2023)

Harbor Freight Tools (Harbor Freight) is recalling certain Central Hydraulics High Position Motorcycle Lifts with part number 99887. The lift welds or tubing may break, which can allow the lift to fall or drop the motorcycle.

High

NHTSAMar 3, 2023Nationwide• CENTRAL HYDRAULICS

CombiDiagnost R90 R1.1 (Philips) – Compliance Issue (2023)

Low

FDAMar 3, 2023Nationwide• Philips North America

NanoKnife Procedure Pack (Angiodynamics) – RFID Recognition (2023)

Not programmed in accordance with specification. The programming affects the RFID function and does not allow the NanoKnife probes to be recognized by the NanoKnife generator resulting in a delay in procedure

High

FDAMar 2, 2023Nationwide• Angiodynamics, Inc.

Cirq Arm System 2.0 (Brainlab) – Mechanical Instability (2023)

Risk of mechanical instability due to potential manufacturing error of the device

High

FDAMar 2, 2023TX• Brainlab AG Olof-palme-str. 9 Munich Germany

Clobazam 10mg Tablets (Breckenridge) – CGMP Contamination Risk (2023)

CGMP Deviations: Potential risk of Cross Contamination

Class IIModerate

FDAMar 2, 2023Nationwide• Breckenridge Pharmaceutical, Inc

Alprazolam 0.25mg Tablets (Breckenridge) – CGMP Cross Contamination (2023)

CGMP Deviations: Potential risk of Cross Contamination

Class IIModerate

FDAMar 2, 2023Nationwide• Breckenridge Pharmaceutical, Inc

Clobazam 20mg Tablets (Breckenridge) – CGMP Contamination Risk (2023)

CGMP Deviations: Potential risk of Cross Contamination

Class IIModerate

FDAMar 2, 2023Nationwide• Breckenridge Pharmaceutical, Inc

Calcitonin Nasal Spray (Endo) – Impurity Specifications (2023)

Failed Impurities/Degradation Specifications and Subpotent Drug: High Out of Specification results for a known and unknown impurity as well as low Out of Specification results for assay.

Class IIModerate

FDAMar 2, 2023Nationwide• Endo Pharmaceuticals, Inc.

Alprazolam 1mg Tablets (Breckenridge) – CGMP Cross Contamination (2023)

CGMP Deviations: Potential risk of Cross Contamination

Class IIModerate

FDAMar 2, 2023Nationwide• Breckenridge Pharmaceutical, Inc

Alprazolam 0.5mg Tablets (Breckenridge) – CGMP Cross Contamination (2023)

CGMP Deviations: Potential risk of Cross Contamination

Class IIModerate

FDAMar 2, 2023Nationwide• Breckenridge Pharmaceutical, Inc

Alprazolam Tablets (Breckenridge) – CGMP Contamination Risk (2023)

CGMP Deviations: Potential risk of Cross Contamination

Class IIModerate

FDAMar 2, 2023Nationwide• Breckenridge Pharmaceutical, Inc

Trilogy EV300 Ventilator (Philips Respironics) – Oxygen Accuracy (2023)

The accuracy of delivered oxygen may deviate below the required tolerance of 5% from setpoint when providing high concentration oxygen therapy. Additionally, if equipped, the internal FiO2 sensor may indicate a value higher than the device is actually delivering. This may lead to under delivery of oxygen.

High

FDAMar 1, 2023Nationwide• Philips Respironics, Inc.

Trilogy Evo O2 Ventilator (Philips Respironics) – Oxygen Accuracy (2023)

High

FDAMar 1, 2023Nationwide• Philips Respironics, Inc.

Express Mini 500 Chest Drain (Atrium) – Insufficient Instructions (2023)

The Instructions for Use (IFU) for the Pneumostat Chest Drain Valve and the Express Mini 500 Dry Seal Chest Drains do not provide sufficient precaution against draining the device for continued use. Additionally, the IFUs do not provide sufficient precaution or warning against the use of the device outside the healthcare setting.

Low

FDAMar 1, 2023Nationwide• Atrium Medical Corporation

Pneumostat Chest Drain Valve (Atrium) – Insufficient Instructions (2023)

Low

FDAMar 1, 2023Nationwide• Atrium Medical Corporation